Clinical trial
Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients…
NCT00241124 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00241124 |
|---|---|
| Title | Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes |
| Official title | A Randomized, Double Blind, Double Dummy, Parallel Group, Active-Controlled Study To Evaluate The Effectiveness Of Morning Versus Evening Doses Of 320 Mg Valsartan Versus 40 Mg Lisinopril On The 24 Hour Blood Pressure Profile In Patients With Hypertension And Non-Insulin Dependent Diabetes |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | valsartan, lisinopril |
| Enrollment | 1,099 |
| Start date | Apr 1, 2004 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Oct 18, 2005 |
| Last update posted | Nov 23, 2011 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: